Xing Lai Sun
Vorsitzender bei Xian Rejoy Technology Investment Co. Ltd.
Profil
Xing Lai Sun is currently the Chairman of Xian Rejoy Technology Investment Co. Ltd.
and Director of Xi'an Lijun Pharmaceutical Co., Ltd.
Previously, she worked as an Executive Director at SSY Group Ltd.
from 2010 to 2011.
Ms. Sun earned a Master's in Business Administration from Hong Kong Metropolitan University in 2002.
Aktive Positionen von Xing Lai Sun
| Unternehmen | Position | Beginn |
|---|---|---|
Xi'an Lijun Pharmaceutical Co., Ltd.
 Xi'an Lijun Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Part of Prime United Industries Ltd., Xi'an Lijun Pharmaceutical Co., Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. The company is based in Xian, China. Xi'an Lijun Pharmaceutical Co. was acquired by United Investments Group Ltd. from SSY Group Ltd. on October 31, 2014 for $99.61 million. | Direktor/Vorstandsmitglied | 25.03.2010 |
| Xian Rejoy Technology Investment Co. Ltd. | Vorsitzender | 09.09.2011 |
Ehemalige bekannte Positionen von Xing Lai Sun
| Unternehmen | Position | Ende |
|---|---|---|
| SSY GROUP LIMITED | Direktor/Vorstandsmitglied | 29.07.2011 |
Ausbildung von Xing Lai Sun
| Hong Kong Metropolitan University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Xi'an Lijun Pharmaceutical Co., Ltd.
Xi'an Lijun Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Part of Prime United Industries Ltd., Xi'an Lijun Pharmaceutical Co., Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. The company is based in Xian, China. Xi'an Lijun Pharmaceutical Co. was acquired by United Investments Group Ltd. from SSY Group Ltd. on October 31, 2014 for $99.61 million. | Health Technology |
| Xian Rejoy Technology Investment Co. Ltd. |
